1 (Image 1)
Chemical structure diagram of erythromycin, illustrating its molecular composition and arrangement characteristic of this macrolide antibiotic.*
Erythromycin Tablet, Film Coated
Product Images NDC 0093-5572
3 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 0093-5572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
Label for Erythromycin Tablets, USP 250 mg film-coated tablets by Teva Pharmaceuticals USA, Inc. The package contains 30 tablets, with an NDC of 0093-5571-56. Instructions mention adult dosage of one tablet every six hours and storage conditions. The label also indicates manufacturing in Bulgaria by Balkanpharma-Dupnitsa AD.*
1 (Image 3)
Label for Erythromycin Tablets, USP 500 mg, film-coated tablets indicated for further processing. The label states a quantity of 30 tablets. Manufactured for Teva Pharmaceuticals USA, Inc. It includes dosage information, storage instructions, and manufacturing details from Bulgaria. A barcode and serialization coding area are also present.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
